Skip to main content
Erschienen in: Journal of Gastroenterology 12/2010

01.12.2010 | Original Article—Liver, Pancreas, and Biliary Tract

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease

verfasst von: Tomoko Hatta, Yasunari Fujinaga, Masumi Kadoya, Hitoshi Ueda, Hiroaki Murayama, Masahiro Kurozumi, Kazuhiko Ueda, Michiharu Komatsu, Tadanobu Nagaya, Satoru Joshita, Ryo Kodama, Eiji Tanaka, Tsuyoshi Uehara, Kenji Sano, Naoki Tanaka

Erschienen in: Journal of Gastroenterology | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

To assess the degree of hepatic fat content, simple and noninvasive methods with high objectivity and reproducibility are required. Magnetic resonance imaging (MRI) is one such candidate, although its accuracy remains unclear. We aimed to validate an MRI method for quantifying hepatic fat content by calibrating MRI reading with a phantom and comparing MRI measurements in human subjects with estimates of liver fat content in liver biopsy specimens.

Methods

The MRI method was performed by a combination of MRI calibration using a phantom and double-echo chemical shift gradient-echo sequence (double-echo fast low-angle shot sequence) that has been widely used on a 1.5-T scanner. Liver fat content in patients with nonalcoholic fatty liver disease (NAFLD, n = 26) was derived from a calibration curve generated by scanning the phantom. Liver fat was also estimated by optical image analysis. The correlation between the MRI measurements and liver histology findings was examined prospectively.

Results

Magnetic resonance imaging measurements showed a strong correlation with liver fat content estimated from the results of light microscopic examination (correlation coefficient 0.91, P < 0.001) regardless of the degree of hepatic steatosis. Moreover, the severity of lobular inflammation or fibrosis did not influence the MRI measurements.

Conclusions

This MRI method is simple and noninvasive, has excellent ability to quantify hepatic fat content even in NAFLD patients with mild steatosis or advanced fibrosis, and can be performed easily without special devices.
Literatur
1.
Zurück zum Zitat Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26.CrossRefPubMed Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26.CrossRefPubMed
2.
Zurück zum Zitat Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.CrossRefPubMed Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–57.CrossRefPubMed
3.
Zurück zum Zitat Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.CrossRefPubMed Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002;123:1705–25.CrossRefPubMed
4.
Zurück zum Zitat Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7.CrossRefPubMed Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960–7.CrossRefPubMed
5.
Zurück zum Zitat Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.CrossRefPubMed
6.
Zurück zum Zitat Nonomura A, Enomoto Y, Takeda M, Tamura T, Kasai T, Yoshikawa T, et al. Clinical and pathological features of non-alcoholic steatohepatitis. Hepatol Res. 2005;33:116–21.CrossRefPubMed Nonomura A, Enomoto Y, Takeda M, Tamura T, Kasai T, Yoshikawa T, et al. Clinical and pathological features of non-alcoholic steatohepatitis. Hepatol Res. 2005;33:116–21.CrossRefPubMed
7.
Zurück zum Zitat Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.CrossRefPubMed Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–9.CrossRefPubMed
8.
Zurück zum Zitat Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.CrossRefPubMed Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.CrossRefPubMed
9.
10.
Zurück zum Zitat Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–13.CrossRefPubMed Ricci C, Longo R, Gioulis E, Bosco M, Pollesello P, Masutti F, et al. Noninvasive in vivo quantitative assessment of fat content in human liver. J Hepatol. 1997;27:108–13.CrossRefPubMed
11.
Zurück zum Zitat Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–50.CrossRefPubMed
12.
Zurück zum Zitat Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–94.PubMed Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–94.PubMed
13.
Zurück zum Zitat Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Radiology. 1984;153:195–201.PubMed Lee JK, Dixon WT, Ling D, Levitt RG, Murphy WA. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Radiology. 1984;153:195–201.PubMed
14.
Zurück zum Zitat Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287–93.CrossRefPubMed Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging. 1997;15:287–93.CrossRefPubMed
15.
Zurück zum Zitat Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19:373–82.PubMed Delfaut EM, Beltran J, Johnson G, Rousseau J, Marchandise X, Cotten A. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19:373–82.PubMed
16.
Zurück zum Zitat Mitchell DG, Kim I, Chang TS, Vinitski S, Consigny PM, Saponaro SA, et al. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041–52.CrossRefPubMed Mitchell DG, Kim I, Chang TS, Vinitski S, Consigny PM, Saponaro SA, et al. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041–52.CrossRefPubMed
17.
Zurück zum Zitat Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol. 1991;156:307–12.PubMed Levenson H, Greensite F, Hoefs J, Friloux L, Applegate G, Silva E, et al. Fatty infiltration of the liver: quantification with phase contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol. 1991;156:307–12.PubMed
18.
Zurück zum Zitat Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology. 2001;218:642–6.PubMed Namimoto T, Yamashita Y, Mitsuzaki K, Nakayama Y, Makita O, Kadota M, et al. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas. Radiology. 2001;218:642–6.PubMed
19.
Zurück zum Zitat Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl. 2003;9:851–6.CrossRefPubMed Rinella ME, McCarthy R, Thakrar K, Finn JP, Rao SM, Koffron AJ, et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transpl. 2003;9:851–6.CrossRefPubMed
20.
Zurück zum Zitat Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol. 2005;29:1143–7.CrossRefPubMed Pilleul F, Chave G, Dumortier J, Scoazec JY, Valette PJ. Fatty infiltration of the liver: detection and grading using dual T1 gradient echo sequences on clinical MR system. Gastroenterol Clin Biol. 2005;29:1143–7.CrossRefPubMed
21.
Zurück zum Zitat Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5, 3.0 T MR imaging. Eur J Radiol. 2007;62:416–22.CrossRefPubMed Schuchmann S, Weigel C, Albrecht L, Kirsch M, Lemke A, Lorenz G, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5, 3.0 T MR imaging. Eur J Radiol. 2007;62:416–22.CrossRefPubMed
22.
Zurück zum Zitat Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna B, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005;237:1048–55.CrossRefPubMed Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna B, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology. 2005;237:1048–55.CrossRefPubMed
23.
Zurück zum Zitat Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology. 2006;240:116–29.CrossRefPubMed Kim SH, Lee JM, Han JK, Lee JY, Lee KH, Han CJ, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging—correlation with histopathologic findings. Radiology. 2006;240:116–29.CrossRefPubMed
24.
Zurück zum Zitat The Examination Committee of Criteria for ‘Obesity Diseases’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘Obesity Disease’ in Japan. Circ J. 2002;66:987–92. The Examination Committee of Criteria for ‘Obesity Diseases’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘Obesity Disease’ in Japan. Circ J. 2002;66:987–92.
25.
Zurück zum Zitat Tanaka N, Ichijo T, Okiyama W, Mutou H, Misawa N, Matsumoto A, et al. Laparoscopic findings in patients with nonalcoholic steatohepatitis. Liver Int. 2006;26:32–8.CrossRefPubMed Tanaka N, Ichijo T, Okiyama W, Mutou H, Misawa N, Matsumoto A, et al. Laparoscopic findings in patients with nonalcoholic steatohepatitis. Liver Int. 2006;26:32–8.CrossRefPubMed
26.
Zurück zum Zitat Tanaka N, Tanaka E, Sheena Y, Komatsu M, Okiyama W, Misawa N, et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int. 2006;26:956–63.CrossRefPubMed Tanaka N, Tanaka E, Sheena Y, Komatsu M, Okiyama W, Misawa N, et al. Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population. Liver Int. 2006;26:956–63.CrossRefPubMed
27.
Zurück zum Zitat Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly-purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–8.CrossRefPubMed Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly-purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–8.CrossRefPubMed
28.
Zurück zum Zitat Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone; 1987. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 2nd ed. Edinburgh: Churchill Livingstone; 1987.
29.
Zurück zum Zitat Szczepaniak LS, Babcock EE, Schick FD, Garg A, Dobbins RL, Burns T, et al. Measurement of intracellular triglyceride stores by H spectroscopy and validation in vivo. Am J Physiol. 1999;276:E977–89.PubMed Szczepaniak LS, Babcock EE, Schick FD, Garg A, Dobbins RL, Burns T, et al. Measurement of intracellular triglyceride stores by H spectroscopy and validation in vivo. Am J Physiol. 1999;276:E977–89.PubMed
30.
Zurück zum Zitat Longo R, Pllesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human steatosis. J Magn Reson Imaging. 1995;5:281–5.CrossRefPubMed Longo R, Pllesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human steatosis. J Magn Reson Imaging. 1995;5:281–5.CrossRefPubMed
31.
Zurück zum Zitat Lodes CC, Felmlee JP, Ehman RL, Sehgal CM, Greenleaf JF, Glover GH, et al. Proton MR chemical shift imaging using double and triple phase contrast acquisition methods. J Comput Assist Tomogr. 1989;13:855–61.CrossRefPubMed Lodes CC, Felmlee JP, Ehman RL, Sehgal CM, Greenleaf JF, Glover GH, et al. Proton MR chemical shift imaging using double and triple phase contrast acquisition methods. J Comput Assist Tomogr. 1989;13:855–61.CrossRefPubMed
32.
Zurück zum Zitat Szumowski J, Coshow WR, Li F, Quinn SF. Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology. 1994;192:555–61.PubMed Szumowski J, Coshow WR, Li F, Quinn SF. Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology. 1994;192:555–61.PubMed
33.
Zurück zum Zitat Cotler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ. Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging. 2007;25:743–8.CrossRefPubMed Cotler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ. Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging. 2007;25:743–8.CrossRefPubMed
34.
Zurück zum Zitat Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, et al. Liver fat: effect of hepatic iron deposit on evaluation with opposed-phase MR imaging. Radiology. 2007;242:450–5.CrossRefPubMed Westphalen AC, Qayyum A, Yeh BM, Merriman RB, Lee JA, Lamba A, et al. Liver fat: effect of hepatic iron deposit on evaluation with opposed-phase MR imaging. Radiology. 2007;242:450–5.CrossRefPubMed
35.
Zurück zum Zitat Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722–30.CrossRefPubMed Iijima H, Moriyasu F, Tsuchiya K, Suzuki S, Yoshida M, Shimizu M, et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res. 2007;37:722–30.CrossRefPubMed
Metadaten
Titel
Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
verfasst von
Tomoko Hatta
Yasunari Fujinaga
Masumi Kadoya
Hitoshi Ueda
Hiroaki Murayama
Masahiro Kurozumi
Kazuhiko Ueda
Michiharu Komatsu
Tadanobu Nagaya
Satoru Joshita
Ryo Kodama
Eiji Tanaka
Tsuyoshi Uehara
Kenji Sano
Naoki Tanaka
Publikationsdatum
01.12.2010
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 12/2010
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0277-6

Weitere Artikel der Ausgabe 12/2010

Journal of Gastroenterology 12/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.